首页 | 本学科首页   官方微博 | 高级检索  
文章检索
  按 检索   检索词:      
出版年份:   被引次数:   他引次数: 提示:输入*表示无穷大
  收费全文   1321篇
  免费   135篇
  国内免费   55篇
化学   1107篇
力学   13篇
综合类   39篇
数学   128篇
物理学   224篇
  2024年   7篇
  2023年   41篇
  2022年   178篇
  2021年   166篇
  2020年   115篇
  2019年   45篇
  2018年   39篇
  2017年   48篇
  2016年   67篇
  2015年   66篇
  2014年   64篇
  2013年   81篇
  2012年   53篇
  2011年   66篇
  2010年   35篇
  2009年   43篇
  2008年   43篇
  2007年   48篇
  2006年   32篇
  2005年   29篇
  2004年   27篇
  2003年   23篇
  2002年   13篇
  2001年   17篇
  2000年   32篇
  1999年   20篇
  1998年   21篇
  1997年   30篇
  1996年   15篇
  1995年   13篇
  1994年   11篇
  1993年   3篇
  1992年   1篇
  1991年   7篇
  1990年   3篇
  1988年   1篇
  1985年   2篇
  1983年   1篇
  1982年   1篇
  1980年   1篇
  1979年   2篇
  1976年   1篇
排序方式: 共有1511条查询结果,搜索用时 15 毫秒
81.
通过水热法合成由临床用药蒙脱石(Montmorillonite, MMT)负载的高效纳米酶氧化铈(Cerium dioxide, CeO2), 通过开展体内外实验, 拓展其在炎症性肠病治疗中的普适性. 结果显示, CeO2@MMT具有良好的类超氧化物歧化酶活性及类过氧化氢酶活性, 并且在小鼠克罗恩病的治疗中体现了明显的疗效及优异的生物安全性, 为CeO2@MMT的应用拓宽了方向.  相似文献   
82.
快速精准的诊断和高效的治疗对于减轻眼部疾病造成的危害至关重要. 在过去的几十年里, 由于具有尺寸小、 比表面积大、 表面易修饰及独特的光/电子/机械性能等优点, 纳米材料已被用于构建不同种类的高性能纳米探针. 其中, 基于其良好的生物相容性, 科学家们已经将硅纳米材料设计为可用于不同眼部疾病诊断与治疗的功能化纳米探针. 本综述主要概述了将硅基纳米探针用于检测和治疗不同眼部疾病(如角膜疾病、 视网膜疾病、 青光眼等)的近期研究进展. 首先, 重点介绍了硅基纳米探针的设计制备及在角膜新生血管、 细菌性角膜炎等角膜疾病的成像检测与治疗中的应用; 然后, 介绍了用于成像检测和治疗视网膜疾病(如色素性视网膜炎和视网膜新生血管)的硅基持续性给药系统的研究成果; 随后, 概述了多功能硅基纳米载药系统的构建及在青光眼治疗领域的应用研究进展; 最后, 简要讨论了将硅基纳米探针用于眼部疾病诊治面临的挑战并对未来的发展前景进行了展望.  相似文献   
83.
The primary clinical diagnosis of Alzheimer’s disease is mainly based on medical history and neuropsychiatric inventory. It is urgent to seek biological indicators with better sensitivity and higher specificity to clinically diagnose and evaluate Alzheimer’s disease. In this work, an electrophoretic method based on 2-thiobarbituric acid derivatization and amperometric detection was developed to determine formaldehyde as a urinary biomarker of Alzheimer’s disease. Under the optimum conditions, the formaldehyde derivative was well separated from the coexisting interferences in urine sample. The limit of detection for formaldehyde was 80.0?nM (2.4?ng/?mL) based on an electrophoretic stacking technology. The average recovery values were in the range of 91.7–110%, and the relative standard deviation values were less than 4.1%. This method has been applied to analyze human urine samples from healthy volunteers and patients with different degrees of Alzheimer’s disease. The assay results showed that the content of urinary formaldehyde in patients suffering Alzheimer’s disease was significantly higher than that in healthy subjects (P?相似文献   
84.
This paper is concerned with a SIR model with saturated and periodic incidence rate and saturated treatment function. By using differential inequality technique, we employ a novel argument to show that the disease‐free equilibrium is globally exponentially stable. The obtained results improve and supplement existing ones. We also use numerical simulations to demonstrate our theoretical results. Copyright © 2015 John Wiley & Sons, Ltd.  相似文献   
85.
In the last 10 years, mesenchymal stem cells (MSCs) have emerged as a therapeutic approach to regenerative medicine, cancer, autoimmune diseases, and many more due to their potential to differentiate into various tissues, to repair damaged tissues and organs, and also for their immunomodulatory properties. Findings in vitro and in vivo have demonstrated immune regulatory function of MSCs and have facilitated their application in clinical trials, such as those of autoimmune diseases and chronic inflammatory diseases. There has been an increasing interest in the role of MSCs in allogeneic hematopoietic stem cell transplantation (HSCT), including hematopoietic stem cell engraftment and the prevention and treatment of graft-versus-host disease (GVHD), and their therapeutic potential has been reported in numerous clinical trials. Although the safety of clinical application of MSCs is established, further modifications to improve their efficacy are required. In this review, we summarize advances in the potential use of MSCs in HSCT. In addition, we discuss their use in clinical trials of the treatment of GVHD following HSCT, the immunomodulatory capacity of MSCs, and their regenerative and therapeutic potential in the field of HSCT.  相似文献   
86.
87.
The amorphous aggregation of Aβ1‐40 peptide is addressed by using micromolding in capillaries. Both the morphology and the size of the aggregates are modulated by changing the contact angle of the sub‐micrometric channel walls. Upon decreasing the hydrophilicity of the channels, the aggregates change their morphology from small aligned drops to discontinuous lines, thereby keeping their amorphous structure. Aβ1‐40 fibrils are observed at high contact angles.  相似文献   
88.
89.
90.
The modelling of the spread of infectious disease is carried out for time t on a measure chain T. Our approach unifies the continuous case and the discrete case . The model is described by the integral equation
where x(t) represents the proportion of the population infected at time t, f(t,x(t)) denotes the proportion of the population newly infected per unit time, and τ is the length of time an individual remains infectious. Using the measure chain calculus, we shall develop criteria for the existence of a nontrivial and nonnegative periodic solution for the modelling equation. The criteria can be implemented numerically, for this we shall give an algorithm as well as illustrative examples.  相似文献   
设为首页 | 免责声明 | 关于勤云 | 加入收藏

Copyright©北京勤云科技发展有限公司  京ICP备09084417号